Assessment of hepatic fibrosis with magnetic resonance elastography
- PMID: 17916548
- PMCID: PMC2276978
- DOI: 10.1016/j.cgh.2007.06.012
Assessment of hepatic fibrosis with magnetic resonance elastography
Abstract
Background & aims: Accurate detection of hepatic fibrosis is crucial for assessing prognosis and candidacy for treatment in patients with chronic liver disease. Magnetic resonance (MR) elastography, a technique for quantitatively assessing the mechanical properties of soft tissues, has been shown previously to have potential for noninvasively detecting liver fibrosis. The goal of this work was to obtain preliminary estimates of the sensitivity and specificity of the technique in diagnosing liver fibrosis, and to assess its potential for identifying patients who potentially can avoid a biopsy procedure.
Methods: MR elastography was performed in 35 normal volunteers and 50 patients with chronic liver disease. MR imaging measurements of hepatic fat to water ratios were obtained to assess the potential for fat infiltration to affect stiffness-based detection of fibrosis.
Results: Liver stiffness increased systematically with fibrosis stage. Receiver operating curve analysis showed that, with a shear stiffness cut-off value of 2.93 kilopascals, the predicted sensitivity and specificity for detecting all grades of liver fibrosis is 98% and 99%, respectively. Receiver operating curve analysis also provided evidence that MR elastography can discriminate between patients with moderate and severe fibrosis (grades 2-4) and those with mild fibrosis (sensitivity, 86%; specificity, 85%). Hepatic stiffness does not appear to be influenced by the degree of steatosis.
Conclusions: MR elastography is a safe, noninvasive technique with excellent diagnostic accuracy for assessing hepatic fibrosis. Based on the high negative predictive value of MR elastography, an initial clinical application may be to triage patients who are under consideration for biopsy examination to assess possible hepatic fibrosis.
Conflict of interest statement
Conflicts of interests: PJR and RLE and their institution hold patents related to this technology and have a potential financial interest in this research.
Figures








Comment in
-
Stiffness and impedance: the new liver biomarkers.Clin Gastroenterol Hepatol. 2007 Oct;5(10):1144-6. doi: 10.1016/j.cgh.2007.07.024. Clin Gastroenterol Hepatol. 2007. PMID: 17916542 No abstract available.
Similar articles
-
Point shear wave elastography method for assessing liver stiffness.World J Gastroenterol. 2014 Apr 28;20(16):4787-96. doi: 10.3748/wjg.v20.i16.4787. World J Gastroenterol. 2014. PMID: 24782633 Free PMC article.
-
MR elastography of the liver at 3.0 T in diagnosing liver fibrosis grades; preliminary clinical experience.Eur Radiol. 2016 Mar;26(3):656-63. doi: 10.1007/s00330-015-3863-4. Epub 2015 Jun 10. Eur Radiol. 2016. PMID: 26060066
-
Point Shear Wave Elastography in Assessment of Hepatic Fibrosis: Diagnostic Accuracy in Subjects With Native and Transplanted Livers Referred for Percutaneous Biopsy.Ultrasound Q. 2016 Sep;32(3):201-7. doi: 10.1097/RUQ.0000000000000219. Ultrasound Q. 2016. PMID: 26808171
-
Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis.Hepatology. 2018 Jan;67(1):260-272. doi: 10.1002/hep.29179. Epub 2017 Nov 15. Hepatology. 2018. PMID: 28370257 Free PMC article. Review.
-
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.J Hepatol. 2021 Oct;75(4):770-785. doi: 10.1016/j.jhep.2021.04.044. Epub 2021 May 13. J Hepatol. 2021. PMID: 33991635
Cited by
-
Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2015 Sep;42(5):582-90. doi: 10.1111/apt.13292. Epub 2015 Jun 29. Aliment Pharmacol Ther. 2015. PMID: 26119353 Free PMC article.
-
Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population.Front Med (Lausanne). 2022 Nov 3;9:1024836. doi: 10.3389/fmed.2022.1024836. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36405611 Free PMC article.
-
Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability.Jpn J Radiol. 2010 Oct;28(8):623-7. doi: 10.1007/s11604-010-0478-1. Epub 2010 Oct 24. Jpn J Radiol. 2010. PMID: 20972864 Free PMC article.
-
Nonalcoholic fatty liver disease: a review and update.Dig Dis Sci. 2010 Mar;55(3):560-78. doi: 10.1007/s10620-009-1081-0. Epub 2010 Jan 26. Dig Dis Sci. 2010. PMID: 20101463 Review.
-
A glitch in the matrix: Age-dependent changes in the extracellular matrix facilitate common sites of metastasis.Aging Cancer. 2020 Dec;1(1-4):19-29. doi: 10.1002/aac2.12013. Epub 2020 Oct 7. Aging Cancer. 2020. PMID: 35694033 Free PMC article.
References
-
- Kim WR, Brown RS, Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227–242. - PubMed
-
- Shaheen NJ, Hansen RA, Morgan DR, Gangarosa LM, Ringel Y, Thiny MT, Russo MW, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128–2138. - PubMed
-
- Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003;9:331–338. - PubMed
-
- Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004;2:1048–1058. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical